Anethole inhibits growth of recently emerged multidrug resistant toxigenic Vibrio cholerae O1 El Tor variant strains in vitro

Journal of Veterinary Medical Science

Volumn 77, Issue 5, 2015, Pages 535-540

  Zahid, M Shamim Hasan ^a   Awasthi, Sharda Prasad ^a   Hinenoya, Atsushi ^a   Yamasaki, Shinji ^a  

^a Osaka Prefecture University   (Japan)

Author keywords

Anethole; El Tor variant; Multidrug resistant; Natural compounds; Vibrio cholerae

Indexed keywords

BACTERIA (MICROORGANISMS); FOENICULUM VULGARE; MYRRHIS ODORATA; VIBRIO CHOLERAE;

ANETHOLE; ANISOLE DERIVATIVE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

CLASSIFICATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENETICS; METABOLISM; MULTIDRUG RESISTANCE; VIBRIO CHOLERAE O1;

ANISOLES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC VARIATION; VIBRIO CHOLERAE O1;

EID: 84930424045     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.14-0664     Document Type: Article

References (28)

1. Abuaita, B. H. and Withey, J. H. 2009. Bicarbonate induces Vibrio cholerae virulence gene expression by enhancing ToxT activity. Infect. Immun. 77: 4111–4120.[Medline][CrossRef]
2. Bax, R., Mullan, N. and Verhoef, J. 2000. The millennium bugs–the need for and development of new antibacterials. Int. J. Antimicrob. Agents 16: 51–59.[Medline][CrossRef]
3. B euchat, L. R. 1976. Sensitivity of Vibrio parahaemolyticus to spices and organic acids. J. Food Sci. 41: 899–902.[CrossRef]
4. C hatterjee, S., Ghosh, K., Raychoudhuri, A., Chowdhury, G., Bhattacharya, M. K., Mukhopadhyay, A. K., Ramamurthy, T., Bhattacharya, S. K., Klose, K. E. and Nandy, R. K. 2009. Incidence, virulence factors, and clonality among clinical strains of non-O1, non-O139 Vibrio cholerae isolates from hospitalized diarrheal patients in Kolkata, India. J. Clin. Microbiol. 47: 1087–1095.[Medline][CrossRef]
5. C linical and Laboratory Standards Institute (CLSI) 2011. Performance Standards for Antimicrobial Susceptibility Testing. 21st Informational Supplement.
6. De, M., De, A. K., Sen, P. and Banerjee, A. B. 2002. Antimicrobial properties of star anise (Illicium verum Hook f). Phytother. Res. 16: 94–95.[Medline][CrossRef]
7. Faruque, S. M., Albert, M. J. and Mekalanos, J. J. 1998. Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol. Mol. Biol. Rev. 62: 1301–1314.[Medline]
8. Faruque, S. M., Tam, V. C., Chowdhury, N., Diraphat, P., Dziejman, M., Heidelberg, J. F., Clemens, J. D., Mekalanos, J. J. and Nair, G. B. 2007. Genomic analysis of the Mozambique strain of Vibrio cholerae O1 reveals the origin of El Tor strains carrying classical CTX prophage. Proc. Natl. Acad. Sci. U.S.A. 104: 5151–5156.[Medline][CrossRef]
9. Ghosh-Banerjee, J., Senoh, M., Takahashi, T., Hamabata, T., Barman, S., Koley, H., Mukhopadhyay, A. K., Ramamurthy, T., Chatterjee, S., Asakura, M., Yamasaki, S., Nair, G. B. and Takeda, Y. 2010. Cholera toxin production by the El Tor variant of Vibrio cholerae O1 compared to prototype El Tor and classical biotypes. J. Clin. Microbiol. 48: 4283–4286.[Medline][CrossRef]
10. Harris, J. B., LaRocque, R. C., Qadri, F., Ryan, E. T. and Calderwood, S. B. 2012. Cholera. Lancet 379: 2466–2476.[Medline][CrossRef]
11. Iwanaga, M., Yamamoto, K., Higa, N., Ichinose, Y., Nakasone, N. and Tanabe, M. 1986. Culture conditions for stimulating cholera toxin production by Vibrio cholerae O1 El Tor. Microbiol. Immunol. 30: 1075–1083.[Medline][CrossRef]
12. Kamruzzaman, M., Bari, S. M. and Faruque, S. M. 2013. In vitro and in vivo bactericidal activity of Vitex negundo leaf extract against diverse multidrug resistant enteric bacterial pathogens. Asian Pac. J. Trop. Med. 6: 352–359.[Medline][CrossRef]
13. Kitaoka, M., Miyata, S. T., Unterweger, D. and Pukatzki, S. 2011. Antibiotic resistance mechanisms of Vibrio cholerae. J. Med. Microbiol. 60: 397–407.[Medline][CrossRef]
14. Kubo, I., Fujita, K. and Nihei, K. 2008. Antimicrobial activity of anethole and related compounds from aniseed. J. Sci. Food Agric. 88: 242–247.[CrossRef]
15. Low Dog, T. 2006. A reason to season: the therapeutic benefits of spices and culinary herbs. Explore (NY) 2: 446–449.[Medline][CrossRef]
16. Morita, M., Ohnishi, M., Arakawa, E., Bhuiyan, N. A., Nusrin, S., Alam, M., Siddique, A. K., Qadri, F., Izumiya, H., Nair, G. B. and Watanabe, H. 2008. Development and validation of a mismatch amplification mutation PCR assay to monitor the dissemination of an emerging variant of Vibrio cholerae O1 biotype El Tor. Microbiol. Immunol. 52: 314–317.[Medline][CrossRef]
17. Nihei, K., Nihei, A. and Kubo, I. 2004. Molecular design of multifunctional food additives: antioxidative antifungal agents. J. Agric. Food Chem. 52: 5011–5020.[Medline][CrossRef]
18. Quilici, M. L., Massenet, D., Gake, B., Bwalki, B. and Olson, D. M. 2010. Vibrio cholerae O1 variant with reduced susceptibility to ciprofloxacin, Western Africa. Emerg. Infect. Dis. 16: 1804–1805.[Medline][CrossRef]
19. Ramamurthy, T., Yamasaki, S., Takeda, Y. and Nair, G. B. 2003. Vibrio cholerae O139 Bengal: Odyssey of a fortuitous variant. Microbes Infect. 5: 329–344.[Medline][CrossRef]
20. Rattanachaikunsopon, P. and Phumkhachorn, P. 2009. Antimicrobial activity of elephant garlic oil against Vibrio cholerae in vitro and in a food model. Biosci. Biotechnol. Biochem. 73: 1623–1627.[Medline][CrossRef]
21. Sanchez, J. and Holmgren, J. 2011. Cholera toxin - a foe & a friend. Indian J. Med. Res. 133: 153–163.[Medline]
22. Sandberg, F. and Corrigan, D. 2001. p. 124. Natural Remedies: their origins and uses. 1st ed., Taylor & Francis, London.
23. Siddique, A. K., Nair, G. B., Alam, M., Sack, D. A., Huq, A., Nizam, A., Longini, I. M. Jr., Qadri, F., Faruque, S. M., Colwell, R. R., Ahmed, S., Iqbal, A., Bhuiyan, N. A. and Sack, R. B. 2010. El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol. Infect. 138: 347–352.[Medline][CrossRef]
24. Sjölund-Karlsson, M., Reimer, A., Folster, J. P., Walker, M., Dahourou, G. A., Batra, D. G., Martin, I., Joyce, K., Parsons, M. B., Boncy, J., Whichard, J. M. and Gilmour, M. W. 2011. Drugresistance mechanisms in Vibrio cholerae O1 outbreak strain, Haiti, 2010. Emerg. Infect. Dis. 17: 2151–2154.[Medline]
25. Son, M. S., Megli, C. J., Kovacikova, G., Qadri, F. and Taylor, R. K. 2011. Characterization of Vibrio cholerae O1 El Tor biotype variant clinical isolates from Bangladesh and Haiti, including a molecular genetic analysis of virulence genes. J. Clin. Microbiol. 49: 3739–3749.[Medline][CrossRef]
26. Thakurta, P., Bhowmik, P., Mukherjee, S., Hajra, T. K., Patra, A. and Bag, P. K. 2007. Antibacterial, antisecretory and antihemorrhagic activity of Azadirachta indica used to treat cholera and diarrhea in India. J. Ethnopharmacol. 111: 607–612.[Medline][CrossRef]
27. Toda, M., Okubo, S., Ikigai, H., Suzuki, T., Suzuki, Y., Hara, Y. and Shimamura, T. 1992. The protective activity of tea catechins against experimental infection by Vibrio cholerae O1. Microbiol. Immunol. 36: 999–1001.[Medline][CrossRef]
28. Tran, H. D., Alam, M., Trung, N. V., Kinh, N. V., Nguyen, H. H., Pham, V. C., Ansaruzzaman, M., Rashed, S. M., Bhuiyan, N. A., Dao, T. T., Endtz, H. P. and Wertheim, H. F. 2012. Multidrug resistant Vibrio cholerae O1 variant El Tor isolated in northern Vietnam between 2007 and 2010. J. Med. Microbiol. 61: 431–437.[Medline][CrossRef]